796 related articles for article (PubMed ID: 8145530)
1. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2.
Parr MB; Kepple L; McDermott MR; Drew MD; Bozzola JJ; Parr EL
Lab Invest; 1994 Mar; 70(3):369-80. PubMed ID: 8145530
[TBL] [Abstract][Full Text] [Related]
2. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2.
Milligan GN; Bernstein DI; Bourne N
J Immunol; 1998 Jun; 160(12):6093-100. PubMed ID: 9637526
[TBL] [Abstract][Full Text] [Related]
3. Effects of the estrous cycle on local humoral immune responses and protection of intranasally immunized female mice against herpes simplex virus type 2 infection in the genital tract.
Gallichan WS; Rosenthal KL
Virology; 1996 Oct; 224(2):487-97. PubMed ID: 8874509
[TBL] [Abstract][Full Text] [Related]
4. The role of gamma interferon in immune resistance to vaginal infection by herpes simplex virus type 2 in mice.
Parr MB; Parr EL
Virology; 1999 Jun; 258(2):282-94. PubMed ID: 10366565
[TBL] [Abstract][Full Text] [Related]
5. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2.
Milligan GN; Bernstein DI
Virology; 1995 Oct; 212(2):481-9. PubMed ID: 7571418
[TBL] [Abstract][Full Text] [Related]
6. Estradiol limits viral replication following intravaginal immunization leading to diminished mucosal IgG response and non-sterile protection against genital herpes challenge.
Gillgrass A; Chege D; Bhavanam S; Kaushic C
Am J Reprod Immunol; 2010 Apr; 63(4):299-309. PubMed ID: 20070285
[TBL] [Abstract][Full Text] [Related]
7. T-cell-mediated mechanisms involved in resolution of genital herpes simplex virus type 2 (HSV-2) infection of mice.
Milligan GN; Dudley-McClain KL; Young CG; Chu CF
J Reprod Immunol; 2004 Apr; 61(2):115-27. PubMed ID: 15063634
[TBL] [Abstract][Full Text] [Related]
8. Protection against genital herpes infection in mice immunized under different hormonal conditions correlates with induction of vagina-associated lymphoid tissue.
Gillgrass AE; Tang VA; Towarnicki KM; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3117-26. PubMed ID: 15709031
[TBL] [Abstract][Full Text] [Related]
9. NK and NKT cell-independent contribution of interleukin-15 to innate protection against mucosal viral infection.
Gill N; Rosenthal KL; Ashkar AA
J Virol; 2005 Apr; 79(7):4470-8. PubMed ID: 15767447
[TBL] [Abstract][Full Text] [Related]
10. Rectal immunization generates protective immunity in the female genital tract against herpes simplex virus type 2 infection: relative importance of myeloid differentiation factor 88.
Tengvall S; O'Hagan D; Harandi AM
Antiviral Res; 2008 Jun; 78(3):202-14. PubMed ID: 18276020
[TBL] [Abstract][Full Text] [Related]
11. Importance of myeloid differentiation factor 88 in innate and acquired immune protection against genital herpes infection in mice.
Tengvall S; Harandi AM
J Reprod Immunol; 2008 Jun; 78(1):49-57. PubMed ID: 17945349
[TBL] [Abstract][Full Text] [Related]
12. Progesterone increases susceptibility and decreases immune responses to genital herpes infection.
Kaushic C; Ashkar AA; Reid LA; Rosenthal KL
J Virol; 2003 Apr; 77(8):4558-65. PubMed ID: 12663762
[TBL] [Abstract][Full Text] [Related]
13. Intravaginal immunization with viral subunit protein plus CpG oligodeoxynucleotides induces protective immunity against HSV-2.
Kwant A; Rosenthal KL
Vaccine; 2004 Aug; 22(23-24):3098-104. PubMed ID: 15297061
[TBL] [Abstract][Full Text] [Related]
14. Decreased vaginal disease in J-chain-deficient mice following herpes simplex type 2 genital infection.
Hendrickson BA; Guo J; Brown I; Dennis K; Marcellino D; Hetzel J; Herold BC
Virology; 2000 May; 271(1):155-62. PubMed ID: 10814580
[TBL] [Abstract][Full Text] [Related]
15. Induction of innate immunity against herpes simplex virus type 2 infection via local delivery of Toll-like receptor ligands correlates with beta interferon production.
Gill N; Deacon PM; Lichty B; Mossman KL; Ashkar AA
J Virol; 2006 Oct; 80(20):9943-50. PubMed ID: 17005672
[TBL] [Abstract][Full Text] [Related]
16. Prolonged exposure to progesterone prevents induction of protective mucosal responses following intravaginal immunization with attenuated herpes simplex virus type 2.
Gillgrass AE; Ashkar AA; Rosenthal KL; Kaushic C
J Virol; 2003 Sep; 77(18):9845-51. PubMed ID: 12941893
[TBL] [Abstract][Full Text] [Related]
17. Estradiol regulates susceptibility following primary exposure to genital herpes simplex virus type 2, while progesterone induces inflammation.
Gillgrass AE; Fernandez SA; Rosenthal KL; Kaushic C
J Virol; 2005 Mar; 79(5):3107-16. PubMed ID: 15709030
[TBL] [Abstract][Full Text] [Related]
18. Comparison of different forms of herpes simplex replication-defective mutant viruses as vaccines in a mouse model of HSV-2 genital infection.
Da Costa XJ; Morrison LA; Knipe DM
Virology; 2001 Sep; 288(2):256-63. PubMed ID: 11601897
[TBL] [Abstract][Full Text] [Related]
19. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes.
Parr MB; Parr EL
J Virol; 1998 Apr; 72(4):2677-85. PubMed ID: 9525585
[TBL] [Abstract][Full Text] [Related]
20. Observations on recovery from and recurrence of HSV-2 infections in adult mice that were rescued from lethal vaginal infection by antiviral therapy.
Parr EL; Holliday EM; Collard MW; Parr MB
Arch Virol; 2005 Sep; 150(9):1885-902. PubMed ID: 15824886
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]